Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference8% 
- Check33 days agoChange DetectedReleased a new version: v3.1.0, replacing the old v3.0.2. This is a core content update reflecting an updated software version.SummaryDifference0.2% 
- Check47 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.5% 
- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.5% 
- Check62 days agoChange DetectedThe web page has added a facility name and location details, while removing specific location terms and listed location countries. This indicates a shift towards a more streamlined presentation of location information.SummaryDifference72% 
- Check69 days agoChange DetectedThe page has been updated to reflect a new completion status and a future date of August 19, 2025, while removing a previous status indicating that it was not actively recruiting and a date of January 14, 2025.SummaryDifference1% 
Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.